Tag : Ruxolitinib

Pediatrics

Cytokine implicated in HLH treatment resistance

Newsemia
Scientists at St. Jude Children’s Research Hospital, UCSF Benioff Children’s Hospitals and Baylor College of Medicine are investigating how to best treat hemophagocytic lymphohistiocytosis (HLH),...
Latest News

Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium

Newsemia
WILMINGTON, Del.–(BUSINESS WIRE)—- $INCY–Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Symposia Source...
Latest News

Incyte Announces Positive Results from a Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo

Newsemia
WILMINGTON, Del.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24INCY&src=ctag" target="_blank">$INCY</a> <a href="https://twitter.com/hashtag/wcd2019?src=hash" target="_blank">#wcd2019</a>–Incyte Announces Positive Results from a Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo Source link...
Pharma / Biotech

Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib.

Newsemia
Related Articles Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib. Leuk Res. 2019 Feb 28;79:38-44 Authors: Gerds...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy